Anna L. Parks
( out of 64 reviews )

Anna L. Parks, MD

Languages spoken: Spanish, English

Clinical Locations

Primary Location

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

  • Dr. Anna Parks is an Assistant Professor in the Division of Hematology & Hematologic Malignancies at the University of Utah and a faculty member of the Center on Aging. She specializes in non-malignant hematologic disorders, with a particular interest in thrombotic disorders. She is committed to providing compassionate, individualized care to each of her patients that emphasizes treating the disease and improving quality of life.

    Dr. Parks is dedicated to advancing the care of her patients through both clinical practice and research. Her research focuses on the intersection of aging and hematology, exploring how we can improve outcomes for older adults with blood disorders. Her work has been funded by the National Institutes of Health and the American Society of Hematology. Dr. Parks is also committed to teaching and mentoring the next generation of leaders in hematology.

    Dr. Parks graduated from Yale University. She received her medical degree, trained in Internal Medicine, served as a Chief Resident, and completed Hematology and Aging Research fellowships at the University of California, San Francisco. She grew up in Salt Lake City and is thrilled to be back. Outside of work, she enjoys cooking, reading fiction and hiking with her family.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)

    Patient Rating

    4.9 /5
    ( out of 64 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    SUGAR HOUSE HEALTH CENTER

    Dr Parks is personable and professional. Excellent provider.

    SUGAR HOUSE HEALTH CENTER

    An excellent caring physician. Her treatment of my condition has been successfully administered thanks to her knowledge and care in monitoring me while I continue with the required treatment.

    SUGAR HOUSE HEALTH CENTER

    Love her, wonderful doctor

    SUGAR HOUSE HEALTH CENTER

    Dr Parks is consistently excellent!

    SUGAR HOUSE HEALTH CENTER

    One of the most caring doctors I have ever had. I am blessed to have her on my team. Thank you Dr Parks!

    SUGAR HOUSE HEALTH CENTER

    Dr. Parks was very thorough, attentive, caring and explained everything clearly.

    SUGAR HOUSE HEALTH CENTER

    I'm am so lucky to have her on this journey. And her staff is amazing!!!

    SUGAR HOUSE HEALTH CENTER

    Anna Parks is awesome. She was informative and friendly and made sure I understood what was going on, what my options were and what to do moving forward.

    SUGAR HOUSE HEALTH CENTER

    Did a very good job at explaining my problems.

  • Dr. Anna Parks is an Assistant Professor in the Division of Hematology & Hematologic Malignancies at the University of Utah and a faculty member of the Center on Aging. She specializes in non-malignant hematologic disorders, with a particular interest in thrombotic disorders. She is committed to providing compassionate, individualized care to each of her patients that emphasizes treating the disease and improving quality of life.

    Dr. Parks is dedicated to advancing the care of her patients through both clinical practice and research. Her research focuses on the intersection of aging and hematology, exploring how we can improve outcomes for older adults with blood disorders. Her work has been funded by the National Institutes of Health and the American Society of Hematology. Dr. Parks is also committed to teaching and mentoring the next generation of leaders in hematology.

    Dr. Parks graduated from Yale University. She received her medical degree, trained in Internal Medicine, served as a Chief Resident, and completed Hematology and Aging Research fellowships at the University of California, San Francisco. She grew up in Salt Lake City and is thrilled to be back. Outside of work, she enjoys cooking, reading fiction and hiking with her family.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)

    Education history

    Undergraduate History of Science & Medicine - Yale University B.A.
    Professional Medical Medicine - University of California, San Francisco School of Medicine M.D.
    Residency Internal Medicine - University of California, San Francisco Resident
    Residency Internal Medicine - University of California, San Francisco Chief Resident
    Fellowship Hematology and Oncology - University of California, San Francisco Fellow
    Fellowship T32 Aging Research - University of California, San Francisco Fellow

    Selected Publications

    Journal Article

    1. Hammoud AO, Wilde N, Gibson M, Parks A, Carrell DT, Meikle AW (2008). Male obesity and alteration in sperm parameters. Fertil Steril, 90(6), 2222-5. (Read full publication)
    2. Cohen AB, Parks AL, Whitson HE, Zieman S, Brown CJ, Boyd C, Covinsky KE, Steinman MA (2021). Succeeding in Aging Research During the Pandemic: Strategies for Fellows and Junior Faculty. J Am Geriatr Soc, 69(1), 8-11. (Read full publication)
    3. Parks AL, Fang MC (2017). Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding. Semin Thromb Hemost, 43(5), 514-524. (Read full publication)
    4. Parks AL, Auerbach AD, Schnipper JL, Anstey JE, Sterken DG, Hecht TEH, Fang MC, Hospital Medicine Reengineering Network (HOMERuN). (2020). COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic. Thromb Res, 196, 355-358. (Read full publication)
    5. Parks AL, McWhirter RM, Evason K, Kelley R (2015). Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?. Journal of gastrointestinal cancer, 46(2), 161-5. (Read full publication)
    6. Stern RJ, Parks A (2016). Teaching High-Value Care on Rounds: Modeling Moderation. JAMA internal medicine, 176(2), 262-3. (Read full publication)
    7. Parks AL, Auerbach AD, Schnipper JL, Bertram A, Jeon SY, Boyle B, Fang MC, Gadrey SM, Siddiqui ZK, Brotman DJ, Hospital Medicine Reengineering Network (HOMERuN (2022). Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals. PloS one, 17(5), e0266944. (Read full publication)
    8. Fang MC, Go AS, Prasad PA, Zhou HX, Parks AL, Fan D, Portugal C, Sung SH, Reynolds (2022). Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Thrombosis research, 216, 97-102. (Read full publication)
    9. Parks AL, Incze M (2022). What Can At-home Genetic Tests Tell Me About My Health?. JAMA internal medicine, 182(6), 691. (Read full publication)
    10. Parks AL, Jeon SY, Boscardin WJ, Steinman MA, Smith AK, Covinsky KE, Fang MC, Shah S (2022). Long-term functional outcomes and mortality after hospitalization for extracranial hemorrhage. Journal of hospital medicine, 17(4), 235-242. (Read full publication)
    11. Fang MC, Reynolds K, Tabada GH, Prasad PA, Sung SH, Parks AL, Garcia E, Portugal C, Fan D, Pai AP, Go A (2023). Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA network open, 6(3), e232338. (Read full publication)
    12. Litt HK, Parks AL, Velazquez A (2023). Blood Clots, or Thrombosis, in Patients With Cancer. JAMA oncology, (Read full publication)
    13. de Jong CMM, de Wit K, Black SA, Gwozdz AM, Masias C, Parks AL, Robert-Ebadi H, Talerico R, Woller SC, Klok F (2023). Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. Journal of thrombosis and haemostasis, (Read full publication)
    14. Parks AL, Stevens S (2023). In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation. Annals of internal medicine, (Read full publication)
    15. Parks AL, Stevens S (2023). NSAIDs and hormonal contraceptives are linked to VTE in women with no previous thrombotic disease. Annals of internal medicine, 176(12), JC143. (Read full publication)
    16. Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens S (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Research and practice in thrombosis and haemostasis, 7(7), 102202. (Read full publication)
    17. Parks AL, Slager SL, Cizik AM, Fang MC, Supiano MA, Katz PP, Witt D (2025). The impact of anticoagulant-related bleeding on quality of life: Development of a novel measure based on perspectives from older adults. PloS one, 20(1), e0316796. (Read full publication)

    Review

    1. Parks AL, Fang MC (2016). Anticoagulation in Older Adults with Multimorbidity. [Review]. Clin Geriatr Med, 32, (2), 331-46. (Read full publication)
    2. Parks AL, Fang M (2023). Periprocedural Anticoagulation. Annals of internal medicine, 176(4), ITC49-ITC64. (Read full publication)
    3. Parks AL, Frankel DS, Kim DH, Ko D, Kramer DB, Lydston M, Fang MC, Shah S (2024). Management of atrial fibrillation in older adults. BMJ (Clinical research ed.), 386, e076246. (Read full publication)
    4. Parks AL, Stevens SM, Woller S (2024). Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations. Thrombosis research, 241, 109097. (Read full publication)
    5. Parks A (2024). Anticoagulation at the end of life: whether, when, and how to treat. Hematology. American Society of Hematology. Education Program, 2024(1), 348-354. (Read full publication)
    6. Liu Y, Parks A (2025). Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A Review. JAMA internal medicine, 185(4), 450-456. (Read full publication)

    Book Chapter

    1. Parks AL, Andreadis C, Damon (2021). Blood Disorders .
    2. Parks AL, Stevens Hereditary Thrombophilias :Pathophysiology, Interpretation and Indications for Testing.

    Commentary

    1. Parks AL, Kohlwes RJ (2018). Refining Risk for Deep Vein Thrombosis in Hospitalized Patients. J Gen Intern Med, 33(1), 6. (Read full publication)
    2. Parks AL, Redberg R (2017). Women in Medicine and Patient Outcomes: Equal Rights for Better Work?. JAMA internal medicine, 177(2), 161. (Read full publication)
    3. Parks AL, Redberg R (2016). Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now. JAMA internal medicine, 176(11), 1672. (Read full publication)
    4. Parks AL, O'Malley P (2016). From Choosing Wisely to Practicing Value-More to the Story. JAMA internal medicine, 176(10), 1571-1572. (Read full publication)
    5. Parks AL, Covinsky K (2016). Anticoagulation in the Very Old. JAMA internal medicine, 176(8), 1184. (Read full publication)
    6. Redberg RF, Parks AL, Rubin J (2021). Persistent Gender Pay Gaps in Medicine: What Is Good for the Goose Is Better for the Gander's Paycheck. JAMA internal medicine, 181(9), 1164. (Read full publication)
    7. Parks AL, Covinsky K (2021). Anticoagulation at the End of Life: Time for a Rational Framework. JAMA internal medicine, 181(8), 1123. (Read full publication)
    8. Parks AL, Redberg R (2017). Dabigatran Compared With Rivaroxaban vs Warfarin-Reply. JAMA internal medicine, 177(5), 744. (Read full publication)
    9. Parks AL, O'Malley P (2017). Applying Academic Detailing and Process Change to Promote Choosing Wisely-Reply. JAMA internal medicine, 177(2), 283. (Read full publication)

    Case Report

    1. Han HJ, Parks AL, Shah MP, Hsu G, Santhosh (2022). An Elusive Seizure. The Neurohospitalist, 12(1), 188-194. (Read full publication)

    Editorial

    1. Incze MA, Parks AL, Stern R (2022). Teaching a Deeper Understanding of the Medical Literature. Journal of general internal medicine, 38(4), 1-2. (Read full publication)
    2. Litt HK, Parks AL, Velazquez A Blood Clots, or Thrombosis, in Patients with Cancer.
    3. Parks A (2024). A sobering reminder and call to action: Preventing inpatient deaths from pulmonary emboli with a wraparound strategy. Journal of hospital medicine, (Read full publication)

    Abstract

    1. Parks AL, Kambhampati S, Fakhri B, Andreadis C, Gray L, Wong SW, Shah N, Fang MC (2021). Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma. [Abstract]. Leuk Lymphoma, 62(4), 1003-1006. (Read full publication)
    2. Parks AL, Jeon SY, Boscardin WJ, Steinman MA, Smith AK, Fang MC, Shah SJ (2021). Long-term individual and population functional outcomes in older adults with atrial fibrillation. [Abstract]. J Am Geriatr Soc, 69, 1570-1578. (Read full publication)
    3. Brondfield S, Mulvey CK, Parks AL, et al (2021). Got Stage Fright? A Fellow-Led Initiative to Improve Cancer Staging Documentation. . International journal of cancer,

    Video/Film/CD/Web/Podcast

    1. Parks AL, Fang M (2018). Web M&M: Isolated Clot, Real Error.

  • News & Podcasts

    Huntsman Cancer Institute News